HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

447.919

-5.566-1.23%

Number of Gainers:6

Number of Losers:42

Number of Flat:3

PE:- -

High:453.507

Open:453.447

Low:445.681

Close:453.486

Volume:184.14M

Turnover:4.17B

Market Cap:2.83T

Float Cap:1.97T

Loading ...

CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points

Haidilao shares plummet over 12% to a two-year low as founder's spouse reportedly sells at a discount

Haidilao Shareholders Price Block Trade at 10.62 HKD Per Share, 6.7% Below Tuesday's Close

Haidilao's Stock Plunges on Reports of Major Shareholder Share Sale

Hygeia Healthcare Earns Outperform Rating with HK$14.69 Price Target from Huachuang Securities

HK-Listed HBM Climbs on Initiating Next Phase of Asthma Drug Study

Hong Kong Stock Market Movers: HBM Holdings-B (02142) Climbs Over 4% in Morning Session After Positive Asthma Trial Results and Stock Connect Inclusion

Jinhai Med Tech Surges Over 21% Intraday as Minimally Invasive Business Jumps More Than Threefold in H1

HAIDILAO (06862) Plunges Over 10% in Morning Trade as Pre-Market Block Deal Sparks Share Sale Speculation

MicroPort Artemis Dream Intracranial Stent Enters China NMPA Innovative Device Review Program

HBM Holdings' Asthma Therapy Shows Promising Phase II Results and Moves to Phase III

HBM Says Partner Windward Bio Starts Phase 3 Asthma Trial of Twice-Yearly TSLP Antibody Hbm9378/win378

Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

THOMSON REUTERS

5万治疗费背后，“毛孩子”的晚年谁来守护？宠物抗癌险应运而生

BAIRONG AI-W (06608) Announces Share Buyback on September 8, Spending HK$77,200

Bairong Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 4.98

HYGEIA HEALTH Spends HK$1.55 Million on Share Buyback on September 8

Hygeia Healthcare Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

Sunac Services Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation

China Resources Beer Declares Interim Dividend of HKD 0.516 Per Share for H1 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK1583/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":447.91943,"timestamp":1789097374556,"preClose":453.48572,"halted":0,"volume":184139183,"delay":0,"changeRate":-0.012274,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-5.566284,"latestTime":"09-11 11:29:34","open":453.44696,"high":453.50705,"low":445.6806,"amount":4167081069,"amplitude":0.017258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789099200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":2.061246,"peRate":43.541097,"turnoverRate":0.001774,"increases":6,"decrements":42,"flats":1,"marketCap":2833772730624,"floatMarketCap":1968902215744},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":453.50705,"amplitude":0.017258,"preClose":453.48572,"low":445.6806,"pbRate":"2.061246","latestPrice":447.91943,"volume":184139183,"delay":0,"open":453.44696,"prevYearClose":503.90085,"prevWeekClose":481.394,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":481.394,"twentyDayClose":480.55,"sixtyDayClose":406.275,"secType":"PLATE","market":"HK","turnoverRate":0.001774,"peRate":43.541097,"marketCap":2833772730624,"floatMarketCap":1968902215744,"timestamp":1789097374556,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":6,"down":42,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191216573","title":"CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points","url":"https://stock-news.laohu8.com/highlight/detail?id=1191216573","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191216573?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:06","pubTimestamp":1788933977,"startTime":"0","endTime":"0","summary":"China's innovative drug sector is swinging back to a market led by company fundamentals and stock-specific alpha, according to a research note from CLSA. The influence of particular company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","KURE","BK1589","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140022370","title":"Haidilao shares plummet over 12% to a two-year low as founder's spouse reportedly sells at a discount","url":"https://stock-news.laohu8.com/highlight/detail?id=1140022370","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140022370?lang=en_us&edition=fundamental","pubTime":"2026-09-09 12:01","pubTimestamp":1788926469,"startTime":"0","endTime":"0","summary":"Haidilao (06862.HK) experienced a sharp selloff during Monday's trading session, with shares tumbling more than 12% at one point to HK$10, marking the lowest level since August 2024. By the time of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1604","LU2488822045.USD","BK1233","BK1589","06862","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183458371","title":"Haidilao Shareholders Price Block Trade at 10.62 HKD Per Share, 6.7% Below Tuesday's Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1183458371","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183458371?lang=en_us&edition=fundamental","pubTime":"2026-09-09 12:00","pubTimestamp":1788926428,"startTime":"0","endTime":"0","summary":"According to transaction documents reviewed by media, shareholder SP NP of Haidilao has raised HK$2.75 billion (US$350.8 million) by offloading 259 million shares in the hotpot chain operator.The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","BK1604","LU2488822045.USD","06862","EWH","BK1591","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144829306","title":"Haidilao's Stock Plunges on Reports of Major Shareholder Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1144829306","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144829306?lang=en_us&edition=fundamental","pubTime":"2026-09-09 11:51","pubTimestamp":1788925905,"startTime":"0","endTime":"0","summary":"Shares of HAIDILAO tumbled on Monday morning, falling more than 10% in early trading, following reports that a major shareholder plans to sell a significant stake in the hotpot chain.According to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","06862","BK1604","LU2488822045.USD","BK1591","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199800320","title":"Hygeia Healthcare Earns Outperform Rating with HK$14.69 Price Target from Huachuang Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1199800320","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199800320?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:48","pubTimestamp":1788922124,"startTime":"0","endTime":"0","summary":"Huachuang Securities has issued a research report maintaining its \"Outperform\" recommendation for Hygeia Healthcare (06078), setting a price target of HK$14.69 based on a 15x price-to-earnings...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078","BK1583","EWH","LU0329678337.USD","LU2488822045.USD","161027","LU0329678170.USD","BK1209","LU0737861772.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666033309","title":"HK-Listed HBM Climbs on Initiating Next Phase of Asthma Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666033309","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666033309?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:47","pubTimestamp":1788922062,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed HBM climbs on initiating next phase of asthma drug study** Shares of HBM Holdings2142.HKclimb 3.7% to HK$15.09** Therapeutics developer says its partner Windward Bio AG reportedpositive","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N45102M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141984241","title":"Hong Kong Stock Market Movers: HBM Holdings-B (02142) Climbs Over 4% in Morning Session After Positive Asthma Trial Results and Stock Connect Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1141984241","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141984241?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:42","pubTimestamp":1788921769,"startTime":"0","endTime":"0","summary":"Shares of HBM Holdings-B (02142) surged more than 4% during Tuesday's morning trading session, with the stock last changing hands at HK$15.23, up 4.67%, on turnover of approximately HK$59.8...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1583","BK4585","BK1574","BK1161","KCAI","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178973209","title":"Jinhai Med Tech Surges Over 21% Intraday as Minimally Invasive Business Jumps More Than Threefold in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=1178973209","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178973209?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:31","pubTimestamp":1788921085,"startTime":"0","endTime":"0","summary":"Jinhai Med Tech (02225) surged more than 21% during Tuesday's trading session, extending its cumulative gain to nearly 60% since being included in the Stock Connect program. As of the time of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1589","BK1100","02225","00853","BK1150","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129110635","title":"HAIDILAO (06862) Plunges Over 10% in Morning Trade as Pre-Market Block Deal Sparks Share Sale Speculation","url":"https://stock-news.laohu8.com/highlight/detail?id=1129110635","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129110635?lang=en_us&edition=fundamental","pubTime":"2026-09-09 09:54","pubTimestamp":1788918851,"startTime":"0","endTime":"0","summary":"Shares of HAIDILAO (06862) plunged over 10% in morning trading, pressuring sentiment in the Hong Kong market.At the time of writing, the stock had fallen 9.14% to HK$10.34, with turnover reaching...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","KCAI","BK1604","VXUS","BK1583","BK4585","BK1233","LU2488822045.USD","BK1589","06862","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666716953","title":"MicroPort Artemis Dream Intracranial Stent Enters China NMPA Innovative Device Review Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666716953","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666716953?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:16","pubTimestamp":1788884201,"startTime":"0","endTime":"0","summary":"MicroPort Artemis Dream intracranial stent enters China NMPA innovative device review programMicroPort’s Artemis Dream intracranial sirolimus-eluting stent entered China’s NMPA Innovative Medical Devi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL5nfbwg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1585","BK1589","00853","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167922243","title":"HBM Holdings' Asthma Therapy Shows Promising Phase II Results and Moves to Phase III","url":"https://stock-news.laohu8.com/highlight/detail?id=1167922243","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167922243?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:58","pubTimestamp":1788872333,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) has announced that its partner, Windward Bio AG, has reported positive interim results from the Phase II portion of the POLARIS-1 clinical trial evaluating HBM9378/WIN378 for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1161","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320273","title":"HBM Says Partner Windward Bio Starts Phase 3 Asthma Trial of Twice-Yearly TSLP Antibody Hbm9378/win378","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320273","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320273?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:18","pubTimestamp":1788869907,"startTime":"0","endTime":"0","summary":"HBM says partner Windward Bio starts Phase 3 asthma trial of twice-yearly TSLP antibody HBM9378/WIN378HBM Holdings highlighted positive interim Phase 2 asthma results for HBM9378/WIN378, an ultra-long","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4WknG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320213","title":"Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320213?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869848,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA60HVBV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02142","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187149909","title":"5万治疗费背后，“毛孩子”的晚年谁来守护？宠物抗癌险应运而生","url":"https://stock-news.laohu8.com/highlight/detail?id=1187149909","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187149909?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868869,"startTime":"0","endTime":"0","summary":"今年8月底，赵先生的爱犬“旺财”被确诊为淋巴瘤。“那一刻，我下定决心要救治旺财，”赵先生回忆道。然而，当宠物医院递来一张超过5万元的治疗费用清单时，他心头还是猛地一紧。“与旺财相伴10余年，实在不忍心看它被恶性肿瘤折磨，”他无奈地表示。作为众安保险宠物险产品总监，李爽敏锐地注意到，在2015年至2019年间的“养宠爆发期”入手的宠物正陆续步入中老年阶段，肿瘤等老年犬猫高发疾病的诊疗需求随之激增。面...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1209","CANC","LU0329678170.USD","LU0329678337.USD","LU0737861772.HKD","06078","LU2488822045.USD","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163053847","title":"BAIRONG AI-W (06608) Announces Share Buyback on September 8, Spending HK$77,200","url":"https://stock-news.laohu8.com/highlight/detail?id=1163053847","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163053847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:38","pubTimestamp":1788863910,"startTime":"0","endTime":"0","summary":"In a recent regulatory filing, BAIRONG AI-W (06608) disclosed a share repurchase transaction executed on September 8, 2026. The company bought back 15,500 shares at a total cost of HK$77,200.The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK1587","BK1583","BK1131","BK1109","06608"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665661324","title":"Bairong Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 4.98","url":"https://stock-news.laohu8.com/highlight/detail?id=2665661324","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665661324?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:33","pubTimestamp":1788863638,"startTime":"0","endTime":"0","summary":"Bairong files HKEX next-day disclosure return on share buyback at HKD 4.98Bairong filed a next-day disclosure return showing a buyback of 15,500 shares on Sept. 8.Shares were repurchased on HKEX at HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3jxCst:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1131","BK1109","06608","BK1587","BK1575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164983756","title":"HYGEIA HEALTH Spends HK$1.55 Million on Share Buyback on September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1164983756","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164983756?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:54","pubTimestamp":1788861260,"startTime":"0","endTime":"0","summary":"HYGEIA HEALTH (06078) has announced that on September 8, 2026, the company repurchased 151,000 shares for a total consideration of HK$1.5549 million.The buyback was executed at a per-share price ranging between HK$10.28 and HK$10.30, according to the company's official statement.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1583","LU0329678337.USD","BK1209","LU0737861772.HKD","LU0329678170.USD","06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329697","title":"Hygeia Healthcare Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329697","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329697?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:47","pubTimestamp":1788860859,"startTime":"0","endTime":"0","summary":"Hygeia Healthcare files HKEX next-day disclosure return on share buyback cancellationHygeia Healthcare filed a next-day disclosure return showing a buyback of 151,000 shares on Sept. 8.All repurchased","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2qCKjj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0329678337.USD","LU0329678170.USD","06078","LU2488822045.USD","LU0737861772.HKD","BK1209","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329846","title":"Sunac Services Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329846","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329846?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:38","pubTimestamp":1788860307,"startTime":"0","endTime":"0","summary":"Sunac Services files HKEX next-day return disclosing share buyback for cancellationSunac Services reported an on-market buyback of 200,000 shares on Sept. 8.Shares were repurchased at HKD 0.82–0.84 ea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbGg3JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1229","BK1542","BK1583","BK1555","BK1258","01918","BK1585","01516","BK1240","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665224326","title":"China Resources Beer Declares Interim Dividend of HKD 0.516 Per Share for H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665224326","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665224326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:28","pubTimestamp":1788859698,"startTime":"0","endTime":"0","summary":"China Resources Beer declares interim dividend of HKD 0.516 per share for H1 2026China Resources Beer declared an interim dividend of HKD 0.516 per share for the six months ended June 30, 2026.Shareho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1J9GQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","IE0008368742.USD","BK1521","IE00BPRC5H50.USD","LU0328353924.USD","BK1510","80291","00291","SG9999006514.SGD","LU1720050803.USD","BK1589","LU1023057109.AUD","LU1769817179.HKD","BK1578","LU0359201612.USD","LU1794554557.SGD","BK1604","BK1180","IE00B543WZ88.USD","BK1570","IE0031814852.USD","LU1769817096.USD","LU0359202008.SGD","IE00B5MMRT66.SGD","LU1328615791.USD","CRHKY","IE00B0169L03.USD","IE00B29SXG58.USD","IE00B031HY20.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":407,"code":"91000000","status":"200"}]}}